<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestionSet xmlns="http://soap.sforce.com/2006/04/metadata">
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q1_R1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q2</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q2_R1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q3</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q4</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q5</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q6</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q7</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q8</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q8_R1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q9</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q10</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q11</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q12</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q12_R1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q12_R2</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Submission_InitiationCriteria_Q13</assessmentQuestionDeveloperNames>
    <developerName>Lanadelumab_Submission_InitiationCriteria_QS</developerName>
    <name>Lanadelumab_Submission_InitiationCriteria_QS</name>
</AssessmentQuestionSet>
